PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-615

I am also looking forward to the quarterly but alas not expecting any ground breaking new news, just a recap and a conformation of what is going on.

We all need to remember that Monepantel has not failed any research, medical or scientific test to which it has been applied. We should also remember that the mTOR path way is comparatively brand new science. The Hubble telescope was lunched before mTOR was discovered
https://www.nasa.gov/image-feature/goddard/2022/celebrating-hubbles-32nd-birthday-with-an-eclectic-galaxy-grouping
https://www.pnas.org/doi/10.1073/pnas.1716173114

We should also remember.
Board members have many hundreds of thousands of dollars invested in PAA .
Testing takes time.
Bureaucrats of any kind seem becoming more reluctant to be responsible for making a decision be it for ethics approval or a simple housing DA. god I know about the latter.
Dr Aston has stated that PAA could be sold to low ball offers but was not interested.
And Blah Blah.

Good luck to all